| The impact of obesity on the cardiovascular system I Csige, D Ujvárosy, Z Szabó, I Lőrincz, G Paragh, M Harangi, S Somodi Journal of diabetes research 2018 (1), 3407306, 2018 | 619 | 2018 |
| Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel AFG Cicero, A Colletti, G Bajraktari, O Descamps, DM Djuric, M Ezhov, ... Nutrition reviews 75 (9), 731-767, 2017 | 544 | 2017 |
| The role of nutraceuticals in statin intolerant patients M Banach, AM Patti, RV Giglio, AFG Cicero, AG Atanasov, G Bajraktari, ... Journal of the American College of Cardiology 72 (1), 96-118, 2018 | 281 | 2018 |
| Study of factors influencing the decreased HDL associated PON1 activity with aging I Seres, G Paragh, E Deschene, T Fulop Jr, A Khalil Experimental gerontology 39 (1), 59-66, 2004 | 273 | 2004 |
| Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. G Kerekes, Z Szekanecz, H Dér, Z Sándor, G Lakos, L Muszbek, I Csipö, ... The Journal of rheumatology 35 (3), 398-406, 2008 | 257 | 2008 |
| Rheumatoid arthritis and metabolic syndrome G Kerekes, MT Nurmohamed, MA Gonzalez-Gay, I Seres, G Paragh, ... Nature Reviews Rheumatology 10 (11), 691-696, 2014 | 243 | 2014 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 220 | 2021 |
| Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ... Atherosclerosis 277, 234-255, 2018 | 209 | 2018 |
| Angiogenesis in rheumatoid arthritis Z Szekanecz, T Besenyei, G Paragh, AE Koch Autoimmunity 42 (7), 563-573, 2009 | 174 | 2009 |
| Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia G Paragh, P Balla, E Katona, I Seres, A Égerházi, I Degrell European archives of psychiatry and clinical neuroscience 252, 63-67, 2002 | 170 | 2002 |
| Influence of iron on bone homeostasis E Balogh, G Paragh, V Jeney Pharmaceuticals 11 (4), 107, 2018 | 161 | 2018 |
| Assessment of subclinical vascular disease associated with ankylosing spondylitis N Bodnár, G Kerekes, I Seres, G Paragh, J Kappelmayer, ZG Némethné, ... The Journal of Rheumatology 38 (4), 723-729, 2011 | 145 | 2011 |
| Photodynamic therapy and pain: A systematic review JM Ang, IB Riaz, MU Kamal, G Paragh, NC Zeitouni Photodiagnosis and photodynamic therapy 19, 308-344, 2017 | 142 | 2017 |
| The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia G Paragh, I Seres, Z Balogh, Z Varga, I Kárpáti, J Mátyus, L Újhelyi, ... Nephron 80 (2), 166-170, 1998 | 140 | 1998 |
| Ultrarestrictive opioid prescription protocol for pain management after gynecologic and abdominal surgery J Mark, DM Argentieri, CA Gutierrez, K Morrell, K Eng, AD Hutson, ... JAMA network open 1 (8), e185452-e185452, 2018 | 127 | 2018 |
| Serum paraoxonase activity changes in uremic and kidney-transplanted patients G Paragh, L Asztalos, I Seres, Z Balogh, L Löcsey, I Kárpáti, J Mátyus, ... Nephron 83 (2), 126-131, 1999 | 121 | 1999 |
| Induction of NLRP3 inflammasome activation by heme in human endothelial cells J Erdei, A Tóth, E Balogh, BB Nyakundi, E Bányai, B Ryffel, G Paragh, ... Oxidative medicine and cellular longevity 2018 (1), 4310816, 2018 | 118 | 2018 |
| Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS … AJ Vallejo-Vaz, A Akram, SRK Seshasai, D Cole, GF Watts, GK Hovingh, ... Atherosclerosis Supplements 22, 1-32, 2016 | 116 | 2016 |
| New insights in synovial angiogenesis Z Szekanecz, T Besenyei, G Paragh, AE Koch Joint Bone Spine 77 (1), 13-19, 2010 | 113 | 2010 |
| Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage M Harangi, I Seres, Z Varga, G Emri, Z Szilvássy, G Paragh, É Remenyik European Journal of Clinical Pharmacology 60, 685-691, 2004 | 111 | 2004 |
Zsolt KarányiDept. of Internal Medicine, University of DebrecenVerified email at med.unideb.hu